These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22318315)

  • 41. Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.
    Healy ME; Chow JD; Byrne FL; Breen DS; Leitinger N; Li C; Lackner C; Caldwell SH; Hoehn KL
    J Hepatol; 2015 Mar; 62(3):599-606. PubMed ID: 25450719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-carbohydrate diet disrupts the association between insulin resistance and weight gain.
    Leite JO; DeOgburn R; Ratliff JC; Su R; Volek JS; McGrane MM; Dardik A; Fernandez ML
    Metabolism; 2009 Aug; 58(8):1116-22. PubMed ID: 19439329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
    Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
    Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.
    den Boer MA; Voshol PJ; Schröder-van der Elst JP; Korsheninnikova E; Ouwens DM; Kuipers F; Havekes LM; Romijn JA
    Endocrinology; 2006 Oct; 147(10):4553-8. PubMed ID: 16709607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
    Kwon EY; Choi MS
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adropin deficiency worsens HFD-induced metabolic defects.
    Chen S; Zeng K; Liu QC; Guo Z; Zhang S; Chen XR; Lin JH; Wen JP; Zhao CF; Lin XH; Gao F
    Cell Death Dis; 2017 Aug; 8(8):e3008. PubMed ID: 28837146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice.
    Jiang C; Qu A; Matsubara T; Chanturiya T; Jou W; Gavrilova O; Shah YM; Gonzalez FJ
    Diabetes; 2011 Oct; 60(10):2484-95. PubMed ID: 21873554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake.
    Sandu O; Song K; Cai W; Zheng F; Uribarri J; Vlassara H
    Diabetes; 2005 Aug; 54(8):2314-9. PubMed ID: 16046296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
    Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
    Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
    Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice.
    Longo KA; Charoenthongtrakul S; Giuliana DJ; Govek EK; McDonagh T; Qi Y; DiStefano PS; Geddes BJ
    Regul Pept; 2008 Oct; 150(1-3):55-61. PubMed ID: 18453014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
    Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
    Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity.
    Kuhajda FP; Aja S; Tu Y; Han WF; Medghalchi SM; El Meskini R; Landree LE; Peterson JM; Daniels K; Wong K; Wydysh EA; Townsend CA; Ronnett GV
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R116-30. PubMed ID: 21490364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice.
    Ghoshal S; Banerjee S; Zhang J; Niehoff ML; Farr SA; Butler AA
    Peptides; 2021 Dec; 146():170678. PubMed ID: 34695512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
    Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dietary fat content alters insulin-mediated glucose metabolism in healthy men.
    Bisschop PH; de Metz J; Ackermans MT; Endert E; Pijl H; Kuipers F; Meijer AJ; Sauerwein HP; Romijn JA
    Am J Clin Nutr; 2001 Mar; 73(3):554-9. PubMed ID: 11237931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.